High molecular weight Alzheimer's disease amyloid peptide immunoreactivity in human serum and CSF is an immunoglobulin G
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 145 (1) , 241-248
- https://doi.org/10.1016/0006-291x(87)91312-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinPublished by Elsevier ,2004
- Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's DiseaseScience, 1987
- Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer LocusScience, 1987
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptorNature, 1987
- On the uniform source of amyloid in plaques, tangles and vascular depositsNeurobiology of Aging, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984
- Senile dementia of the Alzheimer typeAnnals of Neurology, 1983
- Transport of Propranolol and Lidocaine through the Rat Blood-Brain Barrier. PRIMARY ROLE OF GLOBULIN-BOUND DRUGJournal of Clinical Investigation, 1983
- High-Molecular-Weight Immunoreactive β-Endorphin in Extracts of Human Placenta Is a Fragment of Immunoglobulin GScience, 1980